Chiral effects in adrenocorticolytic action of o,p'-DDD (mitotane) in human adrenal cells

1. Adrenocortical carcinoma (ACC) is a rare malignant disease with poor prognosis. The main pharmacological choice, o,p'-DDD (mitotane), produces severe adverse effects. 2. Since o,p'-DDD is a chir ...